Organisation paid for research Program year 2020 Source: CMS Open Payments

Behavioral Research Specialist LLC

Neither a doctor nor a teaching hospital

Research payments

$390,708

19 payments

Through program year 2020, Behavioral Research Specialist LLC is reported as receiving $390,708 in research payments, across 19 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$162,373	15
2019	Research	$228,335	4

Breakdown

Who paid Research payments · program years 2019–2020

Otsuka Pharmaceutical Development & Commercialization, Inc. $281,840 5 payments
Sage Therapeutics, Inc. $108,868 14 payments

Studies the money was for Research payments · program years 2019–2020

Protocol 331-201-00080 A Multicenter, Randomized, Double-Blind Trial of Brexpiprazole Versus Placebo for the Acute Treatment of Manic Episodes, With Or Without Mixed Features, Associated With Bipolar I Disorder $186,962 1 payment
A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of Sage-217 in the Treatment of Adult Subjects With Major Depressive Disorder $101,333 12 payments
Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD $53,505 1 payment
Phase 2, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Trial of Brexpiprazole 1 - 3 Mgday As Monotherapy Or As Combination Therapy in the Treatment of Adults With Post-Traumatic Stress Disorder $20,264 1 payment
A Multicenter, Open-Label Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Bipolar I Disorder $14,029 1 payment
217-Mdd-301 $7,535 2 payments
A Phase 3, Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Trial Evaluating the Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficithyperactivity Disorder Trial 405-201-00014 $7,080 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.